Minutes for the Research for Patient Benefit (RfPB) programme Yorkshire & North East Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 47 and Stage 1 applications to Competition 48.
Date and Location
Thursday 29 September 2022 In Person Meeting
In attendance
Committee members
Dr Judith Cohen (Chair)
Victoria Bartle
Mrs Samina Begum
Dr Nicola Clibbens
Ms Michelle Collinson
Professor Peter Day
Dr Judith Dyson
Mrs Joyce Fox
Dr Ann Henry
Dr Harry Hill
Dr Rachael Kelley
Mrs Ellen Lee
Dr Samuel Smith
Mrs Jan Speechley
Professor Claire Surr
Dr Maureen Twiddy
Ms Alexandra Wright-Hughes
Secretariat
Dr Stuart Haylock (NIHR)
Mr Ben Morgan (NIHR)
Ms Rozie Newman (NIHR)
Mr Conor Ford (NIHR)
Professor Marian Knight (Programme Director)
Observers
Samina Begum (PPIE)
Competition 47 Stage 2 applications considered
NIHR204305: What is the risk of stroke for patients with migraine-like symptoms referred as suspected TIA? A multi-site observational cohort study to inform development of a standardised clinical risk assessment.
Conflicts: Dr Samuel Smith left the room
Final outcome: Rejected
NIHR204357: The clinical and cost-effectiveness of genetic screening in families with autosomal dominant polycystic kidney disease
Conflicts: Dr Harry Hill, Mrs Ellen Lee left the room
Final outcome: Conditional support
NIHR204312: Living well with chronic breathlessness: Improving the sustained use of supported self-management strategies
Conflicts: Dr Judith Cohen, Dr Maureen Twiddy, Ms Michelle Collinson, Ms Alexandra Wright-Hughes left the room
Final outcome: Conditional support
NIHR204327: Named contact care plan for improved outcomes after total knee replacement
Conflicts: None
Final outcome: Conditional support
Competition 48 Stage 1 applications considered
NIHR204963: Assessing the long-term effectiveness of urethroplasty and urethrotomy as treatments for recurrent urethral strictures in men: Long-term follow-up of the OPEN Trial
Conflicts: Mrs Ellen Lee left the room
Outcome: Invite to Stage 2
NIHR204957: Gestational Trophoblastic Disease and Neoplasia: exploring patient’s views and experience of the current pathways to diagnosis and cure.
Conflicts: Dr Harry Hill left the room and Mrs Ellen Lee remained out the room
Outcome: Invited to Stage 2
NIHR204941: An evaluation of the public's and patients' preferences for the surgical management of mitral valve repair: A discrete choice experiment
Conflicts: None
Outcome: Invited to Stage 2
NIHR204924: Milk Donation after baby Loss (MiDAL): a study exploring parent and health care professional views and experiences
Conflicts: None
Outcome: Invited to Stage 2
NIHR204945: Feasibility and acceptability of a remote exercise and lifestyle change intervention to promote health benefits in patients with smaller abdominal aortic aneurysms
Conflicts: Dr Nicola Clibbens, Dr Judith Cohen, Mrs Ellen Lee
Outcome: Invite to Stage 2
NIHR204910: ICalM- Intra-operative Calcium to reduce Maternal Haemorrhage during elective caesarean section: A Triple-Blinded Randomised Placebo Control Pilot Trial
Conflicts: Dr Maureen Twiddy left the room and Dr Judith Cohen remained out of the room
Outcome: Reject
NIHR204906: Communication interventions to support non-speaking autistic children and young people: a systematic review and survey
Conflicts: Dr Maureen Twiddy and Dr Judith Cohen remained out of the room
Outcome: Reject
NIHR204897: Improving UK Tic Services: A study to co-design a service model for children and young people with tic disorders
Conflicts: None
Outcome: Invite to Stage 2
Outcomes Table
The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.
In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.
Stage 2
| Score | Range | Number of applications |
|---|---|---|
| 9.0 - 10.0 | Fundable | 0 |
| 8.0 - 8.9 | Fundable | 0 |
| 7.0 - 7.9 | Fundable | 1 |
| 6.0 - 6.9 | Fundable | 2 |
| 5.0 - 5.9 | Rejected | 1 |
| 4.0 - 4.9 | Rejected | 0 |
| 3.0 - 3.9 | Rejected | 0 |
| 2.0 - 2.9 | Rejected | 0 |
| 1.0 - 1.9 | Rejected | 0 |
Stage 1
| Score | Range | Number of applications |
|---|---|---|
| 9.0 - 10.0 | Invited | 0 |
| 8.0 - 8.9 | Invited | 0 |
| 7.0 - 7.9 | Invited | 0 |
| 6.0 - 6.9 | Invited | 0 |
| 5.0 - 5.9 | Rejected | 2 |
| 4.0 - 4.9 | Rejected | 2 |
| 3.0 - 3.9 | Rejected | 0 |
| 2.0 - 2.9 | Rejected | 0 |
| 1.0 - 1.9 | Rejected | 0 |